GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Scaled Net Operating Assets

Theratechnologies (Theratechnologies) Scaled Net Operating Assets : -0.05 (As of Feb. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Theratechnologies's operating assets for the quarter that ended in Feb. 2024 was $33.64 Mil. Theratechnologies's operating liabilities for the quarter that ended in Feb. 2024 was $37.55 Mil. Theratechnologies's Total Assets for the quarter that ended in Nov. 2023 was $77.77 Mil. Therefore, Theratechnologies's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2024 was -0.05.


Theratechnologies Scaled Net Operating Assets Historical Data

The historical data trend for Theratechnologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Scaled Net Operating Assets Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.32 0.34 0.09 -0.03

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 - -0.09 -0.04 -0.05

Competitive Comparison of Theratechnologies's Scaled Net Operating Assets

For the Biotechnology subindustry, Theratechnologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Theratechnologies's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Theratechnologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Theratechnologies's Scaled Net Operating Assets falls into.



Theratechnologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Theratechnologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Nov. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Nov. 2023 )
=(Operating Assets (A: Nov. 2023 )-Operating Liabilities (A: Nov. 2023 ))/Total Assets (A: Nov. 2022 )
=(37.382-39.671)/93.26
=-0.02

where

Operating Assets(A: Nov. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=77.769 - 40.387
=37.382

Operating Liabilities(A: Nov. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=98.639 - 51.261 - 7.707
=39.671

Theratechnologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Feb. 2024 )
=(Operating Assets (Q: Feb. 2024 )-Operating Liabilities (Q: Feb. 2024 ))/Total Assets (Q: Nov. 2023 )
=(33.637-37.552)/77.769
=-0.05

where

Operating Assets(Q: Feb. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=72.09 - 38.453
=33.637

Operating Liabilities(Q: Feb. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=96.692 - 46.355 - 12.785
=37.552

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Theratechnologies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Theratechnologies (Theratechnologies) Business Description

Traded in Other Exchanges
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.